Atossa Therapeutics ATOS
NASDAQ ATOS
$2.27 +0.32 (+16.41%)
At close: Oct 1, 2026 · 4:00 PM EDT

Atossa Therapeutics (ATOS) Other financing activities (2020 - 2021)

Updated

Atossa Therapeutics' Other financing activities came in at -$1,000 for Q4 2021, compared with -$422.00 a year earlier.

Analysis

Atossa Therapeutics (ATOS) Other financing activities (2020 - 2021) Analysis & Trends

For FY2021, Atossa Therapeutics' Other financing activities was $573,000.

  • Going back by year, Other financing activities was $14,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Atossa Therapeutics 19.46 Mn 19.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -1,000.00
Dec 31, 2020 -422.00
API Access

Atossa Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ATOS&period=max&api_key=YOUR_API_KEY